By expenditures
| Name | Title | Type |
|---|---|---|
| Josh Perkins | Controller; Associate Vp Of Admin & Finance | Auditee |
| Carol Spillum | ASSOCIATE VP OF FINANCE | Auditee |
| Deirdre Hodgson | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 400089 | 2025 | 2026-04-29 | CLIFTONLARSONALLEN LLP | $25.21M |
| 6326 | 2023 | 2023-12-12 | Cliftonlarsonallen LLP | $14.72M |
| 16338 | 2022 | 2022-11-27 | Cliftonlarsonallen LLP | $18.43M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 400089 | 2025 | 2026-04-29 | 1210811 | 2025-002 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210810 | 2025-002 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210809 | 2025-002 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210808 | 2025-002 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210807 | 2025-002 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210806 | 2025-002 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210805 | 2025-002 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210804 | 2025-001 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210803 | 2025-001 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210802 | 2025-001 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210801 | 2025-001 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210800 | 2025-001 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210799 | 2025-001 | Material Weakness | Yes | L |
| 400089 | 2025 | 2026-04-29 | 1210798 | 2025-001 | Material Weakness | Yes | L |
| 6326 | 2023 | 2023-12-12 | 580452 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 580451 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 580450 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 580449 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 580448 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 580447 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 580446 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 4010 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 4009 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 4008 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 4007 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 4006 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 4005 | 2023-001 | Significant Deficiency | - | L |
| 6326 | 2023 | 2023-12-12 | 4004 | 2023-001 | Significant Deficiency | - | L |